- Home
- Publications
- Publication Search
- Publication Details
Title
The pharmacological management of metabolic syndrome
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 11, Issue 4, Pages 397-410
Publisher
Informa UK Limited
Online
2018-01-19
DOI
10.1080/17512433.2018.1429910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulation of inflammatory and immune responses by vitamin D
- (2017) Francesco Colotta et al. JOURNAL OF AUTOIMMUNITY
- 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2017) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
- (2017) Christoph U. Correll et al. World Psychiatry
- A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids
- (2016) Dean G. Karalis ADVANCES IN THERAPY
- The Discovery of Statins
- (2016) Peter Manu et al. AMERICAN JOURNAL OF THERAPEUTICS
- Association between Metabolic Syndrome and Cancer
- (2016) Mehmet Uzunlulu et al. ANNALS OF NUTRITION AND METABOLISM
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. ATHEROSCLEROSIS
- Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries
- (2016) Brendon Stubbs et al. BMC Medicine
- 7. Obesity Management for the Treatment of Type 2 Diabetes
- (2016) DIABETES CARE
- The dangerous link between childhood and adulthood predictors of obesity and metabolic syndrome
- (2016) Maria Felicia Faienza et al. Internal and Emergency Medicine
- Classes of antihypertensive agents and mortality in hypertensive patients with type 2 diabetes—Network meta-analysis of randomized trials
- (2016) Luciana R. Remonti et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Adipose tissue regulates insulin sensitivity: role of adipogenesis,de novolipogenesis and novel lipids
- (2016) U. Smith et al. JOURNAL OF INTERNAL MEDICINE
- 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2016) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials
- (2016) Sripal Bangalore et al. MAYO CLINIC PROCEEDINGS
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death
- (2016) Martin H. Strauss et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
- (2016) Chirag Bavishi et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Determinants for gallstone formation – a new data cohort study and a systematic review with meta-analysis*
- (2016) Daniel Mønsted Shabanzadeh et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
- (2016) Davy Vancampfort et al. World Psychiatry
- Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
- (2016) Sripal Bangalore et al. BMJ-British Medical Journal
- Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials
- (2016) Sripal Bangalore et al. BMJ-British Medical Journal
- Role of sleep quality in the metabolic syndrome
- (2016) David Gozal et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
- (2015) P. Manu et al. ACTA PSYCHIATRICA SCANDINAVICA
- Anti-hypertensive Drug Treatment of Patients with and the Metabolic Syndrome and Obesity: a Review of Evidence, Meta-Analysis, Post hoc and Guidelines Publications
- (2015) Jonathan G. Owen et al. CURRENT HYPERTENSION REPORTS
- Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis
- (2015) Zhi Jian Wang et al. HEART
- Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: A meta-analysis of randomized controlled trials
- (2015) Chi-kin Ip et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Diabetes
- (2015) David M. Nathan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
- (2015) Suetonia C Palmer et al. LANCET
- Pharmacotherapy for the management of obesity
- (2015) Dhiren Patel METABOLISM-CLINICAL AND EXPERIMENTAL
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide: A New Option for the Treatment of Obesity
- (2015) Wesley A. Nuffer et al. PHARMACOTHERAPY
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
- (2015) Christoph U. Correll et al. World Psychiatry
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk
- (2015) Icilma V. Fergus et al. Current Cardiology Reports
- Metabolic syndrome in people with schizophrenia: a review
- (2015) MARC DE HERT et al. World Psychiatry
- Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
- (2015) MARC DE HERT et al. World Psychiatry
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
- (2015) MARC DE HERT et al. World Psychiatry
- Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
- (2014) Nathalie Esser et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The Niemann-Pick C1 Like 1 (NPC1L1) Inhibitor Ezetimibe Improves Metabolic Disease Via Decreased Liver X Receptor (LXR) Activity in Liver of Obese Male Mice
- (2014) Taichi Sugizaki et al. ENDOCRINOLOGY
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis
- (2014) Yuhong Xu et al. PLoS One
- Genetics of metabolic syndrome
- (2014) Alena Stančáková et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
- (2014) D. Keene et al. BMJ-British Medical Journal
- Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus
- (2014) Jun Cheng et al. JAMA Internal Medicine
- Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
- (2014) Guangwei Li et al. Lancet Diabetes & Endocrinology
- Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report
- (2014) Petru Ifteni et al. Therapeutics and Clinical Risk Management
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- Mechanisms of thrombosis in obesity
- (2013) Ilya O. Blokhin et al. CURRENT OPINION IN HEMATOLOGY
- Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review*
- (2013) C. P. Ooi et al. DIABETIC MEDICINE
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
- (2013) Steven E Kahn et al. LANCET
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-Wide Screen for Metabolic Syndrome Susceptibility Loci Reveals Strong Lipid Gene Contribution But No Evidence for Common Genetic Basis for Clustering of Metabolic Syndrome Traits
- (2012) Kati Kristiansson et al. Circulation-Cardiovascular Genetics
- Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
- (2012) Ian J. Neeland et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Bariatric Surgery on the Metabolic Syndrome: A Population-Based, Long-term Controlled Study
- (2012) John A. Batsis et al. MAYO CLINIC PROCEEDINGS
- Active Smoking and Risk of Metabolic Syndrome: A Meta-Analysis of Prospective Studies
- (2012) Kan Sun et al. PLoS One
- Fenofibrate and Metabolic Syndrome
- (2012) Aldi T. Kraja et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
- (2011) Meng Lee et al. ATHEROSCLEROSIS
- Pleiotropic Effects of ARB in Metabolic Syndrome
- (2011) Satoru Yamada Current Vascular Pharmacology
- Cardiovascular disease in recent onset diabetes mellitus
- (2011) Shoichi Yamagishi Journal of Cardiology
- Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials
- (2011) Martina Lukasova et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999-2006
- (2010) A. Mozumdar et al. DIABETES CARE
- Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
- (2010) Eric Bruckert et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The metabolic syndrome
- (2010) Robert H Eckel et al. LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular Disease
- (2010) Benjamin Sadowitz et al. Vascular and Endovascular Surgery
- Combination therapy for treatment or prevention of atherosclerosis: Focus on the lipid-RAAS interaction
- (2009) Kwang Kon Koh et al. ATHEROSCLEROSIS
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
- (2009) Philip J. Barter et al. JOURNAL OF LIPID RESEARCH
- Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population
- (2009) J. P. Reis et al. PEDIATRICS
- Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: The GEMS Study
- (2007) Heide Stirnadel et al. ATHEROSCLEROSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now